Dr. Lowell L Hart
Claim this profileWake Forest Baptist Medical Center / Wake Forest University
Studies Non-Small Cell Lung Cancer
Studies Breast Cancer
6 reported clinical trials
15 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
2Breast Cancer
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Lowell L Hart is currently running
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
Tisotumab Vedotin
for Cancer
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects (unwanted effects) may occur. There are seven parts to this study. In Part A, the treatment will be given to participants every 3 weeks (3-week cycles). In Part B, participants will receive tisotumab vedotin on Days 1, 8, and 15 every 4-week cycle. In Part C, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. In Part D, participants will be given treatment on Day 1 of every 3-week cycle. Participants in Part D will get tisotumab vedotin with either: Pembrolizumab or, Pembrolizumab and carboplatin, or Pembrolizumab and cisplatin In Part E, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. In Part F, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part F will get tisotumab vedotin with pembrolizumab. In Part G, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part G will get tisotumab vedotin with pembrolizumab and carboplatin.
Recruiting1 award Phase 216 criteria
More about Lowell L Hart
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Lowell L Hart has experience with
- Ladiratuzumab Vedotin
- Trastuzumab
- CAB-ROR2-ADC
- PD-1 Inhibitor
- Sapanisertib
- Mirvetuximab Soravtansine
Breakdown of trials Lowell L Hart has run
Non-Small Cell Lung Cancer
Breast Cancer
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lowell L Hart specialize in?
Lowell L Hart focuses on Non-Small Cell Lung Cancer and Breast Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Lowell L Hart currently recruiting for clinical trials?
Yes, Lowell L Hart is currently recruiting for 3 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Lowell L Hart has studied deeply?
Yes, Lowell L Hart has studied treatments such as ladiratuzumab vedotin, Trastuzumab, CAB-ROR2-ADC.
What is the best way to schedule an appointment with Lowell L Hart?
Apply for one of the trials that Lowell L Hart is conducting.
What is the office address of Lowell L Hart?
The office of Lowell L Hart is located at: Wake Forest Baptist Medical Center / Wake Forest University, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest Baptist Medical Center / Wake Forest University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.